drugset / Trial / NCT01137708

CP-690,550 And Oral Contraception Drug-Drug Interaction Study

NCT01137708

Phase 1 Completed 20 enrolled Pfizer
RandomizedCrossoverOpen-labelTreatment

Summary

This study is designed to assess whether co-administration of CP-690,550 and oral contraceptives will effect the metabolism of the oral contraceptives in healthy volunteers.

Timeline

Start
2010-06
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule 150 ug
Subject Tofacitinib Small molecule 30 mg
Subject ethinyl estradiol Small molecule 30 ug

Indications

No indication recorded.